About AccuRx
AccuRx is a company based in London (United Kingdom) founded in 2016. AccuRx has raised $50 million across 4 funding rounds from investors including Encore Capital Group, Lakestar and Trusted Insight. The company has 53 employees as of March 31, 2021. AccuRx offers products and services including Accurx Platform. AccuRx operates in a competitive market with competitors including MedAware, Ameritox, Pyrls, YouScript and Bainbridge Health, among others.
- Headquarter London, United Kingdom
- Employees 53 as on 31 Mar, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Accurx Limited
- Date of Incorporation 17 May, 2016
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
$39.34 M (USD)34as on Jun 30, 2023
-
Net Profit
-$3.89 M (USD)-295as on Jun 30, 2023
-
EBITDA
-$4.26 M (USD)-360as on Jun 30, 2023
-
Total Equity Funding
$50 M (USD)
in 4 rounds
-
Latest Funding Round
$38.07 M (USD), Series B
Sep 15, 2021
-
Investors
Encore Capital Group
& 8 more
-
Employee Count
53
as on Mar 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AccuRx
AccuRx offers a comprehensive portfolio of products and services, including Accurx Platform.
Software for secure interactions between patients and healthcare professionals
People of AccuRx
Unlock access to complete
Funding Insights of AccuRx
AccuRx has successfully raised a total of $50M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $38.07 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AccuRx
AccuRx has secured backing from 9 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Encore Capital Group, Lakestar and Trusted Insight.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment firm
|
Locked | Locked | Locked | |
|
Venture capital co-investments are made in UK later-stage businesses.
|
Locked | Locked | Locked | |
|
Tech-based companies are invested in by Atomico venture capital fund.
|
Locked | Locked | Locked |
Investor details for AccuRx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AccuRx
Investment portfolio details for AccuRx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AccuRx
Detailed financials for AccuRx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accurx Comparisons
Peer comparison for AccuRx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AccuRx
AccuRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedAware, Ameritox, Pyrls, YouScript and Bainbridge Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of an AI based medication dosage and safety managing software for healthcare professionals
|
|
| Locked | Locked | Locked |
Pain medication monitoring solutions are provided for US clinicians.
|
|
| Locked | Locked | Locked |
Cloud-based practical drug information platform for providers
|
|
| Locked | Locked | Locked |
Clinical decision support software for drug interactions is developed.
|
|
| Locked | Locked | Locked |
Provider of a clinical intelligence data analytics platform to monitor patient safety and reduce medication errors
|
Detailed competitors of AccuRx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accurx
Complete news archive for AccuRx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AccuRx
AccuRx was founded in 2016.
AccuRx is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
AccuRx is a funded company, having raised a total of $50M across 4 funding rounds to date.
As of Mar 31, 2021, the latest employee count at AccuRx is 53.
Annual revenue of AccuRx is $39.34M as on Jun 30, 2023.
AccuRx was founded in 2016 in London, United Kingdom, within the health technology sector. A platform is operated to improve antibiotic prescribing accuracy in primary care settings. Smart guideline nudges are integrated into clinical workflows, patient engagement tools for self-management are included, and data-driven decision support is provided. Local and national prescribing guidelines tailored to patients are delivered at key workflow trigger points.
AccuRx offers Accurx Platform.
AccuRx has 9 investors. Key investors include Encore Capital Group, Lakestar, Trusted Insight, Atomico, and British Patient Capital.